In conclusion, this study showed that tumor cells of the majority of CRCs display a functional caspase-1/IL-18 axis, part of the inflammasome pathway, that can modulate the IFNγ response elicited by Th1/Tc1 TILs from the tumor microenvironment. The gene discussed is IFNG; the disease is neoplasm.